Records containing: Pulmonary Arterial Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-03-05A Phase 1, Open Label, Randomized, Multiple Dose Study To Assess The Two-Way Drug Interaction Between Sitaxsentan And Low Dose Ritonavir In Healthy Subjects
-
CLINICAL_TRIALS study record update · 2015-03-05A Phase 1, Open Label, Fixed Sequence Design, Multiple Dose Study To Assess The Effect Of Rifampin On The Pharmacokinetics Of Sitaxsentan In Healthy Subjects
-
CLINICAL_TRIALS study record update · 2015-01-26Effects of Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Morbidity and Mortality in Symptomatic Patients With Pulmonary Arterial Hypertension - A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Prospective, Event Driven Phase IV Study
-
CLINICAL_TRIALS study record update · 2015-01-13A Multicenter, Single-arm, Open-label, Phase 3b Study to Assess the Effects of Switching From Flolan® to EFI/ACT-385781A in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2014-12-29ClinicalTrials.gov study NCT01319045
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-09-10An Open Label Pilot Study of Purified (-)-Epicatechin to Improve Hemodynamics in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2014-09-08ClinicalTrials.gov study NCT02023450
-
CLINICAL_TRIALS study record update · 2014-09-01An Open Label, Non-Randomized Pilot Study to Evaluate the Safety and Performance of the GeNO Nitrosyl Delivery System in Subjects Being Evaluated for Orthotopic Heart Transplantation (OHT), or Left Ventricular Assist Device (LVAD) Implantation
-
CLINICAL_TRIALS study record update · 2014-08-29Prospective, Non-interventional, Multi-centre Study. The Observation Period for Each Subject Covers 1 Year of Treatment. One Initial Visit and 4 Follow-up Visits Every 3 Months and One Extra Educational Reinforcement at Baseline and at 6 Months Will be Given to a Group of Patients.
-
CLINICAL_TRIALS study record update · 2014-08-12Oral Iron Supplementation in Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2014-08-11Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2014-08-11A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
-
CLINICAL_TRIALS study record update · 2014-05-05A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2014-04-09Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2014-04-09A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2014-04-09A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2014-03-31Clinical Study of Effects of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2014-02-27Phase Ⅲ Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Arterial Hypertension Patients
-
CLINICAL_TRIALS study record update · 2014-02-27A 24 Week, Randomized, Double Blind, Multicenter, Placebocontrolled Efficacy, Safety, Tolerability and PK Trial of Nilotinib (Tasigna®, AMN107) in Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2014-02-13Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan
-
CLINICAL_TRIALS study record update · 2014-02-04A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-ranging Study of Cicletanine in Subjects With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2014-01-29Treprostinil for Untreated Symptomatic PAH Trial: A 12-Week Multicenter Randomized Double-Blind Placebo-Controlled Trial of the Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2014-01-07Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography
-
CLINICAL_TRIALS study record update · 2013-11-19A Multinational, Multicentre, Randomized, Double-blind Study To Assess The Efficacy And Safety Of Oral Sildenafil 20mg Tid Or Placebo When Added To Bosentan In The Treatment Of Subjects, Aged 18 Years And Above, With Pulmonary Arterial Hypertension (Pah)
-
CLINICAL_TRIALS study record update · 2013-08-20Detection, Estimation and Characterization of Pulmonary Blood Pressure by Transthoracic Parametric Doppler (TPD)